Renaissance Capital logo

Depression device maker Brainsway sets terms for $30 million US IPO

April 3, 2019
Brainsway logo

Brainsway, which sells medical devices that use magnetic stimulation to treat depression and OCD, announced terms for its IPO on Wednesday.

The Jerusalem, Israel-based company plans to raise $30 million by offering 2.5 million ADSs at a price of $11.94, the as-converted last close of its shares listed on the TASE ($5.97), at two shares per ADS. At $11.94, Brainsway would command a fully diluted market value of $129 million.

Brainsway was founded in 2003 and booked $16 million in sales for the 12 months ended December 31, 2018. It plans to list on the Nasdaq under the symbol BWAY. Cantor Fitzgerald, Raymond James and Oppenheimer & Co. are the joint bookrunners on the deal.